Alexandria, VA -- Restraining the use of some patients' unaffected upper limb during the subacute phase following stroke does not appear to generate greater…
Aug 3, 2009
Washington, DC - Kefir, one of the world's oldest "health" drinks, did little to prevent diarrhea in young children being treated with antibiotics, say…
Aug 3, 2009
Almost half of Bangladeshi women with young children experience violence from their husbands, and their children appear to have a higher risk of recent…
Aug 3, 2009
Researchers at the University of Minnesota and National Institutes of Health have identified a new function for the protein missing in people with the most common and ultimately lethal form of childhood muscular dystrophy.
Aug 3, 2009
A team of researchers, led by chemical engineering and materials science professor Michael Tsapatsis in the University of Minnesota's Institute of Technology…
Aug 3, 2009
Men diagnosed with prostate cancer have a number of treatments to choose from, but it's a daunting task to figure out the right mix of therapies for an individual patient.
Aug 3, 2009
Brain scientists and cardiac surgeons at Johns Hopkins have evidence from 227 heart bypass surgery patients that long-term memory losses and cognitive problems…
Aug 3, 2009
Children's after-school activities often consist of sedentary behavior such as watching television, but after-school programs that offer physical activity and healthy snacks could be the best place for children's health.
Aug 3, 2009
Rosemont, Ill -- A new study published in the August 2009 issue of the Journal of Bone and Joint Surgery (JBJS) finds that two years after anterior cervical…
Aug 3, 2009
Thin-film zeolite membranes with tiny, molecule-sized pores are one step closer to replacing the energy-intensive processes now used in industrial separations, a group of academic researchers is reporting.
Aug 3, 2009
DALLAS -- Aug. 3, 2009 -- The new anti-wrinkle facial filler Dysport, which could be used as an alternative to Botox, noticeably reduced frown lines between…
Aug 2, 2009
A member of a new class of antiretroviral drugs is safe and effective for patients beginning treatment against HIV, according to researchers who have completed a two-year multisite phase III clinical trial comparing it with standard antiretroviral drugs.
Aug 2, 2009
SAN FRANCISCO (August 1, 2009) -- Non-small cell lung cancer patients who have progressed on a cetuximab-containing regimen may respond to erlotinib, Fox Chase…
Aug 1, 2009
SAN FRANCISCO (August 1, 2009) -- Previously untreated non-small cell lung cancer (NSCLC) patients over the age of 70 respond well to a combination of…
Aug 1, 2009
